4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-001849
Options or other derivatives
- HEAD OF R&D acquired 930,945 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/form4-04022021_060425.xml…